Geevasinga Nimeshan, Menon Parvathi, Nicholson Garth A, Ng Karl, Howells James, Kril Jillian J, Yiannikas Con, Kiernan Matthew C, Vucic Steve
Westmead Clinical School, University of Sydney, Sydney, New South Wales, Australia.
Northcott Neuroscience Laboratory, ANZAC Research Institute, Sydney, New South Wales, Australia.
JAMA Neurol. 2015 Nov;72(11):1268-74. doi: 10.1001/jamaneurol.2015.1872.
The identification of the chromosome 9 open reading frame 72 (c9orf72) gene hexanucleotide repeat expansion represents a major advance in the understanding of amyotrophic lateral sclerosis (ALS) pathogenesis. The pathophysiological mechanism by which the c9orf72 gene expansion leads to neurodegeneration is not yet elucidated. Cortical hyperexcitability is potentially an important pathophysiological process in sporadic ALS and familial ALS (FALS).
To investigate whether cortical hyperexcitability forms the pathophysiological basis of c9orf72 FALS using the threshold-tracking transcranial magnetic stimulation technique.
DESIGN, SETTING, AND PARTICIPANTS: Prospective case-control single-center study that took place at hospitals and outpatient clinics from January 1, 2013, to January 1, 2015. Clinical and functional assessments along with transcranial magnetic stimulation studies were taken on 15 patients with c9orf72 FALS and 11 asymptomatic expansion carriers of c9orf72 who were longitudinally followed up for 3 years. Results were compared with 73 patients with sporadic ALS and 74 healthy control participants.
Cortical excitability variables, including short-interval intracortical inhibition, were measured in patients with c9orf72 FALS and results were compared with asymptomatic c9orf72 carriers, patients with sporadic ALS, and healthy control participants.
Mean (SD) short-interval intracortical inhibition was significantly reduced in patients with c9orf72 FALS (1.2% [1.8%]) and sporadic ALS (1.6% [1.2%]) compared with asymptomatic c9orf72 expansion carriers (10.2% [1.8%]; F = 16.1; P < .001) and healthy control participants (11.8% [1.0%]; F = 16.1; P < .001). The reduction of short-interval intracortical inhibition was accompanied by an increase in intracortical facilitation (P < .01) and motor-evoked potential amplitude (P < .05) as well as a reduction in the resting motor threshold (P < .05) and cortical silent period duration (P < .001).
This study establishes cortical hyperexcitability as an intrinsic feature of symptomatic c9orf72 expansion-related ALS but not asymptomatic expansion carriers.
9号染色体开放阅读框72(c9orf72)基因六核苷酸重复序列扩增的鉴定代表了在理解肌萎缩侧索硬化症(ALS)发病机制方面的一项重大进展。c9orf72基因扩增导致神经变性的病理生理机制尚未阐明。皮质兴奋性过高可能是散发性ALS和家族性ALS(FALS)中一个重要的病理生理过程。
使用阈值跟踪经颅磁刺激技术研究皮质兴奋性过高是否构成c9orf72 FALS的病理生理基础。
设计、地点和参与者:2013年1月1日至2015年1月1日在医院和门诊诊所进行的前瞻性病例对照单中心研究。对15例c9orf72 FALS患者和11例c9orf72无症状扩增携带者进行了临床和功能评估以及经颅磁刺激研究,并对其进行了为期3年的纵向随访。将结果与73例散发性ALS患者和74例健康对照参与者进行比较。
在c9orf72 FALS患者中测量皮质兴奋性变量,包括短间隔皮质内抑制,并将结果与无症状c9orf72携带者、散发性ALS患者和健康对照参与者进行比较。
与无症状c9orf72扩增携带者(10.2%[1.8%];F = 16.1;P <.001)和健康对照参与者(11.8%[1.0%];F = 16.1;P <.001)相比,c9orf72 FALS患者(1.2%[1.8%])和散发性ALS患者(1.6%[1.2%])的平均(标准差)短间隔皮质内抑制显著降低。短间隔皮质内抑制的降低伴随着皮质内易化增加(P <.01)、运动诱发电位幅度增加(P <.05)以及静息运动阈值降低(P <.05)和皮质静息期持续时间缩短(P <.001)。
本研究确定皮质兴奋性过高是有症状的c9orf72扩增相关ALS的一个内在特征,但不是无症状扩增携带者的特征。